Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm.

Zhang F, Kent KC, Yamanouchi D, Zhang Y, Kato K, Tsai S, Nowygrod R, Schmidt AM, Liu B.

Ann Surg. 2009 Sep;250(3):416-23. doi: 10.1097/SLA.0b013e3181b41a18.

2.

The novel function of advanced glycation end products in regulation of MMP-9 production.

Zhang F, Banker G, Liu X, Suwanabol PA, Lengfeld J, Yamanouchi D, Kent KC, Liu B.

J Surg Res. 2011 Dec;171(2):871-6. doi: 10.1016/j.jss.2010.04.027. Epub 2010 May 11.

3.

Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.

Serban AI, Stanca L, Geicu OI, Munteanu MC, Costache M, Dinischiotu A.

J Diabetes. 2015 Jan;7(1):114-24. doi: 10.1111/1753-0407.12154. Epub 2014 Apr 29.

PMID:
24666836
4.

A novel histone deacetylase inhibitor reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice.

Vinh A, Gaspari TA, Liu HB, Dousha LF, Widdop RE, Dear AE.

J Vasc Res. 2008;45(2):143-52. Epub 2007 Oct 24.

PMID:
17957103
5.

Recombinant human thrombomodulin suppresses experimental abdominal aortic aneurysms induced by calcium chloride in mice.

Lai CH, Shi GY, Lee FT, Kuo CH, Cheng TL, Chang BI, Ma CY, Hsu FC, Yang YJ, Wu HL.

Ann Surg. 2013 Dec;258(6):1103-10. doi: 10.1097/SLA.0b013e31827df7cb.

PMID:
23295319
6.

Association of polymorphisms of the receptor for advanced glycation end products gene and susceptibility to sporadic abdominal aortic aneurysm.

Yao Y, Zhuang J, Li Y, Jing B, Li H, Li J, Shao C, Li K, Wang H.

Biomed Res Int. 2015;2015:394126. doi: 10.1155/2015/394126. Epub 2015 Feb 18.

7.

Cigarette smoking increases aortic dilatation without affecting matrix metalloproteinase-9 and -12 expression in a modified mouse model of aneurysm formation.

Bergoeing MP, Arif B, Hackmann AE, Ennis TL, Thompson RW, Curci JA.

J Vasc Surg. 2007 Jun;45(6):1217-1227. Epub 2007 Mar 29.

8.

Inhibition of EP4 signaling attenuates aortic aneurysm formation.

Yokoyama U, Ishiwata R, Jin MH, Kato Y, Suzuki O, Jin H, Ichikawa Y, Kumagaya S, Katayama Y, Fujita T, Okumura S, Sato M, Sugimoto Y, Aoki H, Suzuki S, Masuda M, Minamisawa S, Ishikawa Y.

PLoS One. 2012;7(5):e36724. doi: 10.1371/journal.pone.0036724. Epub 2012 May 3.

9.

Up-regulation and coexpression of MIF and matrix metalloproteinases in human abdominal aortic aneurysms.

Verschuren L, Lindeman JH, van Bockel JH, Abdul-Hussien H, Kooistra T, Kleemann R.

Antioxid Redox Signal. 2005 Sep-Oct;7(9-10):1195-202.

PMID:
16115023
10.

Comparison of cell-type-specific vs transmural aortic gene expression in experimental aneurysms.

Sho E, Sho M, Nanjo H, Kawamura K, Masuda H, Dalman RL.

J Vasc Surg. 2005 May;41(5):844-52.

11.

Effects of tissue inhibitor of metalloproteinase 2 deficiency on aneurysm formation.

Xiong W, Knispel R, Mactaggart J, Baxter BT.

J Vasc Surg. 2006 Nov;44(5):1061-6.

12.

Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy.

Ma H, Li SY, Xu P, Babcock SA, Dolence EK, Brownlee M, Li J, Ren J.

J Cell Mol Med. 2009 Aug;13(8B):1751-64. doi: 10.1111/j.1582-4934.2008.00547.x.

13.

Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature.

Carnevale D, Mascio G, D'Andrea I, Fardella V, Bell RD, Branchi I, Pallante F, Zlokovic B, Yan SS, Lembo G.

Hypertension. 2012 Jul;60(1):188-97. doi: 10.1161/HYPERTENSIONAHA.112.195511. Epub 2012 May 21.

14.

Chemokine (C-X-C motif) receptor 4 blockade by AMD3100 inhibits experimental abdominal aortic aneurysm expansion through anti-inflammatory effects.

Michineau S, Franck G, Wagner-Ballon O, Dai J, Allaire E, Gervais M.

Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1747-55. doi: 10.1161/ATVBAHA.114.303913. Epub 2014 May 29.

15.

A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall.

Nagashima H, Aoka Y, Sakomura Y, Sakuta A, Aomi S, Ishizuka N, Hagiwara N, Kawana M, Kasanuki H.

J Vasc Surg. 2002 Jul;36(1):158-63.

16.

Regulatory T cells prevent angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E knockout mice.

Meng X, Yang J, Zhang K, An G, Kong J, Jiang F, Zhang Y, Zhang C.

Hypertension. 2014 Oct;64(4):875-82. doi: 10.1161/HYPERTENSIONAHA.114.03950. Epub 2014 Jul 14.

17.

MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial.

Thompson RW, Baxter BT.

Ann N Y Acad Sci. 1999 Jun 30;878:159-78.

PMID:
10415728
18.

Cathepsin G deficiency reduces periaortic calcium chloride injury-induced abdominal aortic aneurysms in mice.

Wang J, Sukhova GK, Liu J, Ozaki K, Lesner A, Libby P, Kovanen PT, Shi GP.

J Vasc Surg. 2015 Dec;62(6):1615-24. doi: 10.1016/j.jvs.2014.06.004. Epub 2014 Jul 16.

19.
20.

Central role of RAGE-dependent neointimal expansion in arterial restenosis.

Sakaguchi T, Yan SF, Yan SD, Belov D, Rong LL, Sousa M, Andrassy M, Marso SP, Duda S, Arnold B, Liliensiek B, Nawroth PP, Stern DM, Schmidt AM, Naka Y.

J Clin Invest. 2003 Apr;111(7):959-72.

Supplemental Content

Support Center